Wall Street analysts highlight Nvidia, Amazon, Microsoft and Target in broad rating moves

Traders Union
All News
Financial News
Wall Street analyst rating moves

Highlights

Bank of America reiterates buy ratings on Nvidia, Intel, Marvell, Micron and Lam Research, expecting favorable seasonal trends for chip stocks into Q4.
Rosenblatt raises Amazon's price target to $360 from $335, dismissing concerns about agentic commerce disruption in advertising economics.
HSBC upgrades Target to buy from hold, arguing shares are inexpensive given potential earnings upside, while Wells Fargo upgrades Pinnacle Financial and downgrades Ally Financial.

Brokerage calls span chips, cloud and consumer stocks

As reported by CNBC, Wednesday's analyst notes cover a wide group of companies, led by bullish commentary on semiconductor, cloud and large-cap technology names as firms position for the final quarter of the year.

UBS reiterates Apple as neutral, saying its checks show iPhone wait times are relatively unchanged week over week across more than 30 geographies. Bank of America reiterates buy ratings on Nvidia, Intel, Marvell, Micron and Lam Research, arguing investors should own all five chip stocks into the fourth quarter because seasonal trends have historically favored the sector. Deutsche Bank initiates FormFactor as buy, citing rising test intensity tied to AI, while William Blair starts CoreWeave and Nebius Group at outperform, describing both as well placed in AI cloud infrastructure.

Rosenblatt reiterates Amazon as buy and raises its price target to $360 from $335, saying concerns that agentic commerce could disrupt the company's advertising economics are overstated. Piper Sandler also reiterates Microsoft as overweight and lifts its target to $610 from $550, pointing to accelerating Copilot adoption momentum. Morgan Stanley keeps Tesla at equal weight, saying delivery trends appear mixed ahead of the company's report, while Needham reiterates SpaceX as buy and calls it a category leader in orbital infrastructure.

Upgrades and downgrades signal valuation and earnings debates

Outside mega-cap technology, analysts are also reshaping views on banks, retailers, biotech groups and industrial names based on valuation, margin outlook and earnings potential.

Wells Fargo upgrades Pinnacle Financial to overweight from equal weight, citing positive catalysts and a debate over whether investors can gain confidence in a sustainable post-conversion return profile. The same firm downgrades Ally Financial to equal weight from overweight, saying the stock has less upside because of net interest margin pressure from higher interest rates and a tougher credit backdrop linked to elevated gas prices and inflation. Bank of America upgrades Grocery Outlet Holdings to buy from neutral, and HSBC upgrades Target to buy from hold, arguing Target shares look inexpensive if potential earnings upside is included.

Citi initiates Nuvation Bio and Jazz Pharmaceuticals at buy, but downgrades Moderna to sell from neutral, saying oncology optimism is already reflected in its valuation. Oppenheimer upgrades Nice to outperform from perform and initiates Cavco Industries at outperform, while Wolfe initiates Amphenol and Bernstein launches coverage on Arista Networks, Celestica, Lumentum, Coherent and Ciena with outperform ratings. StoneX also initiates Alto Ingredients as buy, citing upside from its ethanol platform and higher-value chemical and ingredient businesses.

TSMC’s potential Texas investment to expand U.S. chip production was highlighted in our earlier coverage, alongside the company’s already massive Arizona buildout. The article noted that while no final decision had been made on Texas, TSMC has been steadily scaling American manufacturing capacity as demand for advanced chips and AI-related infrastructure continues to rise.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.